160 related articles for article (PubMed ID: 35961081)
1. Chemical transformation and cytotoxicity of iron oxide nanoparticles (IONPs) accumulated in mitochondria.
Ruan L; Li H; Zhang J; Zhou M; Huang H; Dong J; Li J; Zhao F; Wu Z; Chen J; Chai Z; Hu Y
Talanta; 2023 Jan; 251():123770. PubMed ID: 35961081
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal iron liberation is responsible for the vulnerability of brain microglial cells to iron oxide nanoparticles: comparison with neurons and astrocytes.
Petters C; Thiel K; Dringen R
Nanotoxicology; 2016; 10(3):332-42. PubMed ID: 26287375
[TBL] [Abstract][Full Text] [Related]
3. Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles.
Soenen SJ; De Smedt SC; Braeckmans K
Contrast Media Mol Imaging; 2012; 7(2):140-52. PubMed ID: 22434626
[TBL] [Abstract][Full Text] [Related]
4. Choose your cell model wisely: The in vitro nanoneurotoxicity of differentially coated iron oxide nanoparticles for neural cell labeling.
Joris F; Valdepérez D; Pelaz B; Wang T; Doak SH; Manshian BB; Soenen SJ; Parak WJ; De Smedt SC; Raemdonck K
Acta Biomater; 2017 Jun; 55():204-213. PubMed ID: 28373085
[TBL] [Abstract][Full Text] [Related]
5. Hepatotoxic and Neurotoxic Potential of Iron Oxide Nanoparticles in Wistar Rats: a Biochemical and Ultrastructural Study.
Mabrouk M; Ibrahim Fouad G; El-Sayed SAM; Rizk MZ; Beherei HH
Biol Trace Elem Res; 2022 Aug; 200(8):3638-3665. PubMed ID: 34704196
[TBL] [Abstract][Full Text] [Related]
6. Iron oxide nanoparticles for biomedical applications: an updated patent review (2015-2021).
Mao Z; Li X; Wang P; Yan H
Expert Opin Ther Pat; 2022 Sep; 32(9):939-952. PubMed ID: 35929879
[TBL] [Abstract][Full Text] [Related]
7. Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells.
Wu HY; Chung MC; Wang CC; Huang CH; Liang HJ; Jan TR
Part Fibre Toxicol; 2013 Sep; 10():46. PubMed ID: 24047432
[TBL] [Abstract][Full Text] [Related]
8. The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways.
Kim E; Kim JM; Kim L; Choi SJ; Park IS; Han JY; Chu YC; Choi ES; Na K; Hong SS
Int J Nanomedicine; 2016; 11():4595-4607. PubMed ID: 27695320
[TBL] [Abstract][Full Text] [Related]
9. Imaging the distribution of iron oxide nanoparticles in hypothermic perfused tissues.
Ring HL; Gao Z; Sharma A; Han Z; Lee C; Brockbank KGM; Greene ED; Helke KL; Chen Z; Campbell LH; Weegman B; Davis M; Taylor M; Giwa S; Fahy GM; Wowk B; Pagotan R; Bischof JC; Garwood M
Magn Reson Med; 2020 May; 83(5):1750-1759. PubMed ID: 31815324
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and biodistribution assessment of curcumin-coated iron oxide nanoparticles: Multidose administration.
Aboushoushah S; Alshammari W; Darwesh R; Elbaily N
Life Sci; 2021 Jul; 277():119625. PubMed ID: 34015288
[TBL] [Abstract][Full Text] [Related]
11. Toward absolute quantification of iron oxide nanoparticles as well as cell internalized fraction using multiparametric MRI.
Girard OM; Ramirez R; McCarty S; Mattrey RF
Contrast Media Mol Imaging; 2012; 7(4):411-7. PubMed ID: 22649047
[TBL] [Abstract][Full Text] [Related]
12. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
13. Impact of Morphology on Iron Oxide Nanoparticles-Induced Inflammasome Activation in Macrophages.
Liu L; Sha R; Yang L; Zhao X; Zhu Y; Gao J; Zhang Y; Wen LP
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41197-41206. PubMed ID: 30398340
[TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis and Characterization of L-Aspartic Acid Coated Iron Oxide Magnetic Nanoparticles (IONPs) For Biomedical Applications.
Salehiabar M; Nosrati H; Davaran S; Danafar H; Manjili HK
Drug Res (Stuttg); 2018 May; 68(5):280-285. PubMed ID: 29036735
[TBL] [Abstract][Full Text] [Related]
15. Endocytotic uptake of iron oxide nanoparticles by cultured brain microglial cells.
Luther EM; Petters C; Bulcke F; Kaltz A; Thiel K; Bickmeyer U; Dringen R
Acta Biomater; 2013 Sep; 9(9):8454-65. PubMed ID: 23727247
[TBL] [Abstract][Full Text] [Related]
16. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models.
Sun Z; Yathindranath V; Worden M; Thliveris JA; Chu S; Parkinson FE; Hegmann T; Miller DW
Int J Nanomedicine; 2013; 8():961-70. PubMed ID: 23494517
[TBL] [Abstract][Full Text] [Related]
18. Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter.
Barbaro D; Di Bari L; Gandin V; Evangelisti C; Vitulli G; Schiavi E; Marzano C; Ferretti AM; Salvadori P
PLoS One; 2015; 10(4):e0123159. PubMed ID: 25874906
[TBL] [Abstract][Full Text] [Related]
19. Investigating the toxic effects of iron oxide nanoparticles.
Soenen SJ; De Cuyper M; De Smedt SC; Braeckmans K
Methods Enzymol; 2012; 509():195-224. PubMed ID: 22568907
[TBL] [Abstract][Full Text] [Related]
20. Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: an integrative study combining cytotoxic, genotoxic and proteomic tools.
Askri D; Cunin V; Béal D; Berthier S; Chovelon B; Arnaud J; Rachidi W; Sakly M; Amara S; Sève M; Lehmann SG
Nanotoxicology; 2019 Oct; 13(8):1021-1040. PubMed ID: 31132913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
